Tag: Fesoterodine

Approximately 33 million Americans live with the symptoms of overactive bladder (OAB) [1.6.1, 1.6.3]. For those seeking treatment, a common question is: **which is better, Myrbetriq or Toviaz?** This article provides a detailed comparison of these two widely prescribed medications.

Recent research from an April 2025 cohort study found that compared to untreated overactive bladder (OAB) patients, fesoterodine was not associated with an increased risk of dementia. However, other studies have shown conflicting results regarding the class of drugs known as anticholinergics, making the answer to **does fesoterodine cause dementia?** highly nuanced.

Overactive bladder (OAB) affects an estimated 33 million American adults, causing symptoms such as urinary frequency and urgency. Toviaz, a brand-name prescription medication containing the active ingredient fesoterodine, is a treatment specifically indicated for managing these bothersome bladder control issues.